Exosomal circular RNAs: A chief culprit in cancer chemotherapy resistance

ElsevierVolume 67, March 2023, 100937Drug Resistance UpdatesAuthor links open overlay panel, , , Abstract

Chemotherapy is one of the primary treatments for malignant tumors. However, the acquired drug resistance hinders clinical efficacy and leads to treatment failure in most patients. Exosomes are cell-derived vesicles with a diameter of 30–150 nm carrying and delivering substances such as DNAs, RNAs, lipids, and proteins for cellular communication in tumor development. Circular RNAs (circRNAs) present covalently closed-loop RNA structures, which regulate tumor cell proliferation, apoptosis, and metastasis by controlling different genes and signaling pathways. CircRNAs are abundant and stably expressed in exosomes. Recent studies have shown that they play critical roles in chemotherapy resistance in various cancers. In this review, we summarized the origin of exosomes and discussed the regulation mechanism of exosomal circRNAs in cancer drug resistance.

AbbreviationTME

tumor microenvironment

RNase

RNA exonuclease or ribonuclease

EVs

Extracellular vesicles

MVBs

multivesicular bodies

NGS

next generation sequencing

IRES

internal ribosome entry site

EMT

epithelial-mesenchymal transition

TACE

transarterial chemoembolization

CAFs

cancer-associated fibroblasts

NSCLC

non-small cell lung cancer

PFS

progression-free survival

MDSCs

myeloid-derived suppressor cells

Keywords

Exosome

Circular RNA (circRNA)

Chemotherapy resistance

Cancer

View full text

© 2023 Elsevier Ltd. All rights reserved.

留言 (0)

沒有登入
gif